Dynamic changes of muscle insulin sensitivity after metabolic surgery.
Sofiya GanchevaMeriem OuniTomas JelenikChrysi KoliakiJulia SzendroediFrederico G S ToledoDaniel F MarkgrafDominik Hans PestaLucia MastrototaroElisabetta De FilippoChristian HerderMarkus JähnertJürgen WeissKlaus StrassburgerMatthias SchlensakAnnette SchürmannMichael RodenPublished in: Nature communications (2019)
The mechanisms underlying improved insulin sensitivity after surgically-induced weight loss are still unclear. We monitored skeletal muscle metabolism in obese individuals before and over 52 weeks after metabolic surgery. Initial weight loss occurs in parallel with a decrease in muscle oxidative capacity and respiratory control ratio. Persistent elevation of intramyocellular lipid intermediates, likely resulting from unrestrained adipose tissue lipolysis, accompanies the lack of rapid changes in insulin sensitivity. Simultaneously, alterations in skeletal muscle expression of genes involved in calcium/lipid metabolism and mitochondrial function associate with subsequent distinct DNA methylation patterns at 52 weeks after surgery. Thus, initial unfavorable metabolic changes including insulin resistance of adipose tissue and skeletal muscle precede epigenetic modifications of genes involved in muscle energy metabolism and the long-term improvement of insulin sensitivity.
Keyphrases
- skeletal muscle
- insulin resistance
- adipose tissue
- weight loss
- dna methylation
- high fat diet
- bariatric surgery
- minimally invasive
- coronary artery bypass
- roux en y gastric bypass
- polycystic ovary syndrome
- gene expression
- gastric bypass
- type diabetes
- poor prognosis
- high fat diet induced
- fatty acid
- metabolic syndrome
- surgical site infection
- genome wide
- glycemic control
- drug induced
- obese patients
- percutaneous coronary intervention
- quantum dots
- binding protein
- endothelial cells